Biomedical Research Center, Korea Institute of Science and Technology, Seongbuk-gu, Seoul 136-791, Korea.
J Cell Biochem. 2010 Oct 1;111(2):508-19. doi: 10.1002/jcb.22738.
Fe65 and Dab1 are adaptor proteins that interact with the cytoplasmic domain of amyloid precursor protein (APP) via phosphotyrosine-binding (PTB) domain and that affect APP processing and Aβ production. Co-expression of Dab1 with Fe65 and APP resumed nuclear translocation of Fe65 despite of its cytoplasmic anchor, APP. The decreased amount of Fe65 bound to APP was shown in co-immunoprecipitation assay from the cells with Dab1 which also displayed the effect on APP processing. These data suggested that Fe65 and Dab1 compete for binding to APP. Surprisingly, we found that Fe65 interacts with Dab1 via C-terminal region of Dab1 and unphosphorylated Dab1 is capable of binding Fe65. Dab1 interacts with the low-density lipoprotein receptor-related protein (LRP) as well as APP through its PTB domain. Dab1 significantly decreased the amount of APP bound to LRP and the level of secreted APP and APP-CTF in LRP expressing cells, unlike Fe65. It implies that overexpression of Dab1 diminish LRP-APP complex formation, resulting in altered APP processing. The competition for overlapped binding site among adaptor proteins may be related to the regulation mechanism of APP metabolism in various conditions.
Fe65 和 Dab1 是衔接蛋白,通过磷酸酪氨酸结合(PTB)结构域与淀粉样前体蛋白(APP)的胞质结构域相互作用,并影响 APP 的加工和 Aβ 的产生。尽管 APP 具有细胞质锚定,但 Dab1 与 Fe65 和 APP 的共表达恢复了 Fe65 的核转位。共免疫沉淀试验显示,与 Dab1 共表达的细胞中与 APP 结合的 Fe65 数量减少,这也显示出对 APP 加工的影响。这些数据表明 Fe65 和 Dab1 竞争与 APP 结合。令人惊讶的是,我们发现 Fe65 通过 Dab1 的 C 端区域与 Dab1 相互作用,并且未磷酸化的 Dab1 能够结合 Fe65。Dab1 通过其 PTB 结构域与低密度脂蛋白受体相关蛋白(LRP)以及 APP 相互作用。与 Fe65 不同,Dab1 显著降低了 LRP 表达细胞中与 LRP 结合的 APP 量以及分泌的 APP 和 APP-CTF 的水平。这意味着 Dab1 的过表达减少了 LRP-APP 复合物的形成,导致 APP 加工的改变。衔接蛋白之间重叠结合位点的竞争可能与各种条件下 APP 代谢的调节机制有关。